TARO-TESTOSTERONE GEL
TARO-TESTOSTERONE GEL
Approved
DIN Number
02463806
Drug Class
Human
Market Date
Oct 31, 2017
Company
HC
Taro Pharmaceuticals Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02463806
AIG Number0106405004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
G03BA03 TESTOSTERONE
Product Specifications
Dosage FormGel
Route of AdministrationTransdermal
AHFS Classification68:08.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TESTOSTERONEActive
Strength: 1 %
Monograph: TESTOSTERONE